About: Memorial Medical Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Memorial Medical Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Modesto, California, United States

Attributes	Values
rdf:type	Item
description	Krankenhaus (de) 병원 (ko) griya sakit (jv) rumah sakik (min) rumoh sakét (ace) مستشفى (ar) hospital d'Estaos Xuníos (ast) lamin pongusapan id Amirika Sorikat (dtp) rumah sakit di Amerika Serikat (id) лікарня в США (uk) בית חולים בארצות הברית (he) মার্কিন যুক্তরাষ্ট্রের একটি হাসপাতাল (bn) ziekenhuis in de Verenigde Staten (nl) healthcare organization in Modesto, California, United States (en)
rdfs:label	Memorial Medical Center (en) Memorial Medical Center (es) Memorial Medical Center (fr) Memorial Medical Center (it) Memorial Medical Center (nl) Memorial Medical Center (de)
skos:prefLabel	Memorial Medical Center (en) Memorial Medical Center (es) Memorial Medical Center (fr) Memorial Medical Center (it) Memorial Medical Center (nl) Memorial Medical Center (de)
name	Memorial Medical Center (en) Memorial Medical Center (es) Memorial Medical Center (fr) Memorial Medical Center (it) Memorial Medical Center (nl) Memorial Medical Center (de)
Freebase ID	wds:Q6815474-56FD4AA1-543B-4075-AF12-595C49C2FFEA
Freebase ID	/m/041557d
ROR ID	wds:Q6815474-9C0839DD-ED00-4CF9-8B28-7C5C46850162
ROR ID	008tsd037
instance of	wds:Q6815474-2548AB12-C52E-4793-AA64-C40A68F9EA8C wds:Q6815474-C8ED4718-D9A7-4913-A011-51F418FC7FD1
instance of	hospital medical organization
country	wds:Q6815474-37E1E2A5-2EDB-4573-B31D-43C1899CE40D
country	United States of America
number of hospital beds	wds:Q6815474-C2FE1E59-5D65-4B4C-B8C8-9CE7CE6246A5
number of hospital beds	423 (xsd:decimal)
inception	wds:Q6815474-195F3520-E090-4F1E-89D3-1556007FB83D
inception	1970-01-01 00:00:00Z (xsd:dateTime)
located in the adm...erritorial entity	wds:Q6815474-DFFE4BFA-C4F6-45D4-9179-D1F75C04C31A
ISNI	wds:Q6815474-80435F07-C061-4F77-BF7F-FAFC00937AE7
coordinate location	wds:Q6815474-D9BF583E-1CF0-4C92-8DDF-1EF37933307C
official website	wds:Q6815474-EB1B500B-EF9B-4FAE-B134-6BF1776C1DF0
located in the adm...erritorial entity	Modesto
ISNI	0000000404510008
coordinate location	POINT(-120.97452 37.66864)
official website	http://www.memorialmedicalcenter.org/
GRID ID	wds:Q6815474-BB674883-59B2-4DFB-BF16-644A4E640B60
parent organization	wds:Q6815474-AAC86755-0516-48C3-8B11-25FFC5C2DA67
GRID ID	grid.429318.5
parent organization	Sutter Health
is owl:sameAs of	Memorial Medical Center
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q6815474 Memorial Medical Center (Modesto, California)
is research site of	Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride Sleep for Stroke Management and Recovery Trial Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy Ruxolitinib Phosphate and Dasatinib or Nilotinib in Treating Patients With Chronic Myeloid Leukemia Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer Vascularized Composite Allotransplantation of the Hand and Upper Extremity (Hand Transplant) S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Bupropion in Reducing Cancer Related Fatigue in Stage I-III Breast Cancer Survivors

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software